Your browser doesn't support javascript.
loading
Monthly mini-dose rituximab for primary anti-PLA2R-positive membranous nephropathy: a personalized approach.
Wang, Song; Deng, Zhenling; Wang, Yue; Bao, Wenhan; Zhou, Sijia; Cui, Zhuan; Zheng, Danxia.
Afiliação
  • Wang S; Department of Nephrology, Peking University Third Hospital, No. 49 North Garden Road, 100191, Beijing, China.
  • Deng Z; Department of Nephrology, Peking University Third Hospital, No. 49 North Garden Road, 100191, Beijing, China.
  • Wang Y; Department of Nephrology, Peking University Third Hospital, No. 49 North Garden Road, 100191, Beijing, China.
  • Bao W; Department of Nephrology, Peking University Third Hospital, No. 49 North Garden Road, 100191, Beijing, China.
  • Zhou S; Department of Nephrology, Peking University Third Hospital, No. 49 North Garden Road, 100191, Beijing, China.
  • Cui Z; Department of Nephrology, Peking University Third Hospital, No. 49 North Garden Road, 100191, Beijing, China.
  • Zheng D; Department of Nephrology, Peking University Third Hospital, No. 49 North Garden Road, 100191, Beijing, China. dxzheng@sina.com.
BMC Nephrol ; 24(1): 146, 2023 05 26.
Article em En | MEDLINE | ID: mdl-37237260
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Autoanticorpos / Glomerulonefrite Membranosa Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: BMC Nephrol Assunto da revista: NEFROLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Autoanticorpos / Glomerulonefrite Membranosa Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: BMC Nephrol Assunto da revista: NEFROLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China